Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions